Rare diseases
Investigational molecules
Locations
Back to Germany1 286 clinical trials in Aachen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of different ropivacaine concentrations in ankle nerve block for hallux valgus (bunion) surgery patients
BelgiumStudy on FOLFIRINOX, Pembrolizumab, and SABR for Patients with Borderline Resectable Pancreatic Cancer
The NetherlandsLong-Term Safety Study of Iptacopan for Adults with IgA Nephropathy After Completing a Previous Study, Including ACE Inhibitors and ARBs Drug Combination
GermanyStudy of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors
GermanyStudy Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy
GermanyStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
GermanyStudy on the Effectiveness of 2LPAPI with Interferon Alfa in Clearing Genital HPV Infections in Patients
BelgiumStudy on Preventing Heart Problems in Patients with Diffuse Large B-Cell Lymphoma Using Dexrazoxane and a Drug Combination
The NetherlandsStudy Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer
GermanyStudy on Durvalumab, Cisplatin, and Gemcitabine for Patients with Extrahepatic Cholangiocarcinoma
GermanyStudy on Stiripentol for Patients Aged 6 and Older with Primary Hyperoxaluria Types 1, 2, or 3
BelgiumStudy Comparing Avutometinib and Defactinib with Other Treatments for Patients with Recurrent Low-Grade Serous Ovarian Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma treatments and various forms of breast cancer therapies, including studies of novel immunotherapy combinations for head and neck cancers.
Advanced therapeutic approaches including targeted treatments and combination therapies are being evaluated for improved patient outcomes.
Research targeting heart failure prevention and management of cardiovascular complications, with emphasis on innovative drug combinations and preventive treatments.
Studies focus on reducing cardiovascular events and improving long-term patient outcomes.
Clinical investigations addressing various chronic conditions, including inflammatory diseases and dermatological disorders.
Evaluating new therapeutic approaches for managing long-term conditions and improving quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
